CompletedNot Applicable

Central Serous Chorioretinopathy: Etiology, Course and Prognosis

Austria50 participantsStarted 2011-04

Plain-language summary

Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Signed informed consent form * Age over 18 years * acute episode of Central Serous Chorioretinopathy * Symptoms for less than two weeks * no treatment on study eye Exclusion Criteria: * bad compliance * protected patient group (pregnant women)

What they're measuring

Clinical Outcome

Timeframe: 2 years

Trial details

NCT IDNCT01378130

SponsorMedical University of Vienna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-04

View on ClinicalTrials.gov More Central Serous Chorioretinopathy trials